VOR Stock Summary and Trading Ideas (Vor Biopharma | NASDAQ:VOR)

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Vor Biopharma trades on the NASDAQ stock market under the symbol VOR.

As of December 11, 2025, VOR stock price climbed to $12.13 with 3,155,677 million shares trading.

VOR has a beta of 4.63, meaning it tends to be more sensitive to market movements. VOR has a correlation of 0.10 to the broad based SPY ETF.

VOR has a market cap of $265.78 million. This is considered a Small Cap stock.

In the last 3 years, VOR traded as high as $151.40 and as low as $2.62.

The top ETF exchange traded funds that VOR belongs to (by Net Assets): VTI, VXF, AVSC, DFSU, BMED.

VOR has underperformed the market in the last year with a return of -40.0%, while the SPY ETF gained +15.5%. In the last 3 month period, VOR fell short of the market, returning -66.3%, while SPY returned +5.9%. However, in the most recent 2 weeks VOR has outperformed the stock market by returning +52.6%, while SPY returned +1.4%.

VOR support price is $9.20 and resistance is $11.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VOR shares will trade within this expected range on the day.